Detection of CYP1A1 protein in human liver and induction by TCDD in precision-cut liver slices incubated in dynamic organ culture

Carcinogenesis

Volumn 19, Issue 8, 1998, Pages 1361-1368

  Drahushuk, Adam T ^a   McGarrigle, Barbara P ^a   Larsen, Kristin E ^b   Stegeman, John J ^c   Olson, James R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Howard Hughes Medical Institute   (United States)

^c WOODS HOLE OCEANOGRAPHIC INSTITUTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANTIGEN RECOGNITION; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; ISOELECTRIC FOCUSING; LIVER CARCINOGENESIS; LIVER CELL CULTURE; LIVER MICROSOME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CROSS REACTIONS; CYTOCHROME P-450 CYP1A1; ENZYME INDUCTION; HUMANS; MALE; MICROSOMES, LIVER; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; TETRACHLORODIBENZODIOXIN;

EID: 0031679527     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.8.1361     Document Type: Article

References (82)

1. Guengerich,F.P. (1993) The 1992 Bernard B. Brodie award lecture; bioactivation and detoxification of toxic and carcinogenic chemicals. Drug Metab. Dispos., 21, 1-6.
2. Guengerich,F.P. (1994) Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol. Lett., 70, 133-138.
3. Puga,A., Nebert, D.W., Mckinnon,R.A. and Menon,A.G. (1997) Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit. Rev. Toxicol., 27, 199-222.
4. Shimada,T., Hayes,C.L., Yamazaki,H., Amin,S., Hecht,S.S., Guengerich,F.P. and Sutter,T.R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56, 2979-2984.
5. Roberts-Thomson,S.J., McManus,M.E., Tukey,R.H., Gonzalez,F.F. and Holder,G.M. (1993) The catalytic activity of four expressed human cytochrome P450s towards benzo[a]pyrene and the isomers of its proximate carcinogen. Biochem. Biophys. Res. Commun., 192, 1373-1379.
6. 32P-postlabeling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and exsmokers. Carcinogensis, 12, 1301-1305.
7. McLemore,T.L., Adelberg,S., Liu,M.C. et al. (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl Cancer Inst., 82, 1333-1339.
8. Raunio,H., Husgafvel-Pursianen,K., Anttila,S., Hietanen,E., Hirvonen,A. and Pelkonen,O. (1995) Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene, 159, 113-121.
9. Petruzzelli,S., Camus,A.M., Carrozzi,L. et al (1988) Long-lasting effects of tobacco smoking on pulmonary drug-metabolising enzymes: a case-control study on lung cancer patients. Cancer Res., 48, 4695-4700.
10. Trell,E., Körsgaard,R., Hood,B., Kitzing,P., Norden,G. and Simonsson,B.G. (1976) Aryl hydrocarbon hydroxylase inducibility and laryngeal carcinomas. Lancet, ii, 140.
11. Trell,E., Körsgaard,R., Kitzing,P., Lundgren,K. and Mattiasson,I. (1978) Aryl hydrocarbon inducibility and carcinoma of oral cavity. Lancet, i, 109.
12. 1450 cDNA probe. Cytogenet. Cell Genet., 46, 574-575.
13. Kawajiri,K., Nakachi,K., Imai,K., Yoshii,A., Shinoda,N. and Watanabe,J. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett., 263, 131-133.
14. Hayashi,S., Watanabe,J., Nakachi,K. and Kawajiri,K. (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450Ial gene. J. Biochem., 110, 407-411.
15. Hayashi,S., Watanabe,J. and Kawajiri,K. (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J. Cancer Res., 83, 866-870.
16. Nakachi,K., Imai,K., Hayashi,S. and Kawajiri,K. (1993) Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53, 2994-2999.
17. Kihara,M., Kihara,M. and Noda,K. (1995) Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis, 16, 2331-2336.
18. Esteller,M., Garcia,A., Martinez-Palones,J.M., Xercavins,J. and Revents,J. (1997) Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. Br. J. Cancer, 75, 1385-1388.
19. Hayashi,S.-I., Watanabe,J., Nakachi,K. and Kawajiri,K. (1991) PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res., 19, 4797.
20. Kawajiri,K., Nakachi,K., Imai,K., Watanabe,J. and Hayashi,S. (1993) The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14, 77-87.
21. Cosma,G., Crofts,F., Taioli,E., Toniolo,P. and Garte,S. (1993) Relationship between genotype and function of the human CYP1A1 gene. J. Toxicol. Environ. Health, 40, 309-316.
22. Spivack,S.D., Fasco,M.J., Walker,V.E. and Kaminsky,L.S. (1997) The molecular epidemiology of lung cancer. Crit. Rev. Toxicol., 27, 319-365.
23. Nebert,D.W. (1989) The Ah locus: genetic differences in toxicity, cancer mutation, and birth defects. Crit. Rev. Toxicol., 20, 153-174.
24. Nebert,D.W. (1991) Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol., 5, 1203-1214.
25. Kouri,R.E., Ratrie,H. and Whitmire,C.E. (1974) Genetic control of susceptibility to 3-methylcholanthrene-induced subcutaneous sarcomas. Int. J. Cancer, 13, 714-720.
26. Quan,T., Reiners,J.J., Bell,A.O., Hong,N. and States,J.C. (1994) Cytotoxicity and genotoxicity of (±)-benzo[a]pyrene-trans-7,8-dihydrodiol in CYP1A1-expressing human fibroblasts quantitatively correlate with CYP1A1 expression level. Carcinogenesis, 15, 1827-1832.
27. Park,J.Y.K., Shigenaga,M.K. and Ames,B.N. (1996) Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. Proc. Natl Acad. Sci. USA, 93, 2322-2327.
28. Cheung,Y.L., Puddicombe,S.M., Gray,T.J.B. and Ioannides,C. (1994) Mutagenicity and CYP1A induction by azobenzenes correlates with their carcinogenicity. Carcinogenesis, 15, 1257-1263.
29. Jacquet,M., Lambert,V., Baudoux,E., Muller,M., Kremers,P. and Gielen,J. (1996) Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence. Eur. J. Cancer, 32A, 1701-1706.
30. 1450) gene: lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1, 20-25.
31. Shields,P.G., Sugimura,H., Caporaso,N.E., Petruzzelli,S.F., Bowman,E.D., Trump,B.F., Weston,A. and Harris,C. (1992) Polycyclic aromatic hydrocarbon-DNA adducts and the CYP1A1 RFLP. Environ. Health Perspect., 98, 191-194.
32. Hirvonen,A., Husgafvel-Pursiainen,K., Karjalainen,A., Anttila,S. and Vainio,H. (1992) Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prevent., 1, 485-489.
33. Jett,J.R., Moses,H.L., Branum,E.L., Taylor,W.F. and Fontana,R.S. (1978) Benzo[a]pyrene metabolism and blast formation in peripheral blood mononuclear cells from smoking and non-smoking populations and lung cancer patients. Cancer, 41, 192-200.
34. Lieberman,J. (1978) Aryl hydrocarbon hydroxylase in bronchogenic carcinoma. New Engl. J. Med., 298, 686-687.
35. Paigen,B., Gurtoo,H.L., Minowada,J., Houten,L., Vincent,R., Paigen,K., Parker,N.B., Ward,E. and Hayner,N.T. (1977) Questionable relation of aryl hydrocarbon hydroxylase to lung cancer risk. N. Engl. J. Med., 297, 346-350.
36. Ward,E., Paigen,B., Steenland,K., Vincent,R., Minowada,J., Gurtoo,H.L., Sartoli,P. and Havens,M.B. (1978) Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer. Int. J. Cancer, 22, 384-389.
37. Ichiba,M., Hagmar,L., Rannug,A., Högstedt,B., Alexandrie,A.K., Carstensen,U. and Hemminki,K. (1994) Aromatic DNA adducts, micronuclei, and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis, 15, 1347-1352.
38. 462: assessment of a role for the rare allele in Carcinogenesis. Cancer Res., 56, 3926-3933.
39. Persson,I., Johansson,I. and Ingelman-Sundberg,M. (1997) In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem. Biophys. Res. Commun., 231, 227-230.
40. Wattenberg,L.W. and Leong,J.L. (1968) Inhibition of the carcinogenic action of 7,12-dimethylbenz(a)anthracene by beta-naphthoflavone. Proc. Soc. Exp. Biol. Med., 128, 940-943.
41. DiGiovanni,J., Berry,D.L., Juchau,M.R. and Slaga,T.J. (1979) 2,3,7,8-Tetrachlorodibenzo-p-dioxin: potent anticarcinogenic activity in CD-1 mice. Biochem. Biophys. Res. Commun., 86, 577-584.
42. Parkinson,A. and Hurwitz,A. (1991) Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects. Gastroenterology, 100, 1157-1164.
43. Wattenberg,L.W. (1985) Chemoprevention of cancer. Cancer Res., 45, 1-8.
44. Cohen,G.M., Bracken,W.M, Iyer,R.P., Berry,D.L., Selkirk,J.K. and Slaga,T.J. (1979) Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene tumor initiation and its relationship to DNA binding. Cancer Res., 39,4027-4033.
45. Koser,P.L., Faletto,M.B., Moccubin,A.E. and Gurtoo,H.L. (1988) The genetics of aflatoxin B1 metabolism. Association of the induction of aflatoxin B1-4-hydroxylase with the transcriptional activation of cytochrome P3-450 gene. J. Biol. Chem., 263, 12584-12595.
46. Pelkonen,O. and Nebert,D.W. (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev., 34, 189-222.
47. Murray,B.P., Edwards,R.J., Murray,S., Singleton,A.M., Davies,D.S. and Boobis,A.R. (1993) Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis, 14, 585-592.
48. Edwards,R.J., Murray,B.P., Murray,S., Schulz,T., Neubert,D., Gant,T.W., Thorgeirsson,S.S., Boobis,A.R. and Davies,D.S. (1994) Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis, 15, 829-836.
49. Zhang,Z., Fasco,M.J., Huang,Z., Guengerich,F.P. and Kaminsky,L.S. (1995) Human cytochrome P4501A1 and P4501A2: R-warfarin metabolism as a probe. Drug Metab. Dispos., 23, 1339-1345.
50. Sesardic,D., Pasanen,M., Pelkonen,O. and Boobis,A.R. (1990) Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues. Carcinogenesis, 11, 1183-1188.
51. Belloc,C., Baird,S., Cosme,J., Lecoeur,S., Gautier,J.C., Challine,D., de Waziers,I., Flinois,J.P. and Beaune,P.H. (1996) Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies. Toxicology, 106, 207-219.
52. Diaz,D., Fabre,I., Daujat,M., Aubert,B.S., Bories,P., Michel,H. and Maurel,P. (1990) Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology, 99, 737-747.
53. Yang,H.Y.L., Namkung,M.J. and Juchau,M.R. (1995) Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis. Biochem. Pharmacol., 49, 717-726.
54. Schweikl,H., Taylor,J.A., Kitareewan,S., Linko,P., Nagorney,D. and Goldstein,J.A. (1993) Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics, 3, 239-249.
55. Omiecinski,C.J., Redlich,C.A. and Costa,P. (1990) Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res., 50, 4315-4321.
56. Hakkola,J., Pasanen,M., Purkunen,R., Saarikoski,S., Pelkonen,O., Mäenpää,J., Rane,A. and Raunio,H. (1994) Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem. Pharmacol., 48, 59-64.
57. Gautier,J.C., Urban,P., Beaune,P. and Pompon,D. (1993) Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the first two steps of benzo[a]pyrene activation. Eur. J. Biochem., 211, 63-72.
58. McKinnon,R.A., Hall,P.D.L.M., Quattrochi,L.C., Tukey,R.H. and McManus,M.E. (1991) Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization. Hepatology, 14, 848-856.
59. Daujat,M., Peryt,B., Lesca,P., Fourtanier,G., Domergue,J. and Maurel,P. (1992) Omeprazole, an inducer of human CYP1A1 and CYP1A2, is not a ligand for the Ah receptor. Biochem. Biophys. Res. Commun., 188, 820-825.
60. Schrenk,D., Stüven,T., Gohl,G., Viebahn,R. and Bock,K.W. (1995) Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachloro-p-dioxin in human hepatocyte cultures. Carcinogenesis, 16, 943-946.
61. Curi-Pedrosa,R., Daujat,M., Pichard,L. et al. (1994) Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. J. Pharmacol. Exp. Ther., 269, 384-392.
62. McManus,M.E., Stupans,I., Ioannoni,B., Burgess,W., Robson,R.A. and Birkett,D.J. (1988) Identification and quantitation in human liver of cytochromes P-450 analogous to rabbit cytochromes P-450 forms 4 and 6. Xenobiotica, 18, 207-216.
63. Adams,D.J., Seilman,S., Amelizad,Z., Oesch,F. and Wolf,C.R. (1985) Identification of human cytochrome P-450 analogous to forms induced by phenobarbital and 3-methylcholanthrene in the rat. Biochem. J., 232, 869-876.
64. Drahushuk,A.T., McGarrigle,B.P., Tai,H.L., Kitareewan,S., Goldstein,J.A. and Olson,J.R. (1996) Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicol. Appl. Pharmacol., 140, 393-403.
65. Park,S.S., Miller,H., Klotz,A.V., Kloepper-Sams,P.J., Stegeman,J.J. and Gelboin,H.V. (1986) Monoclonal antibodies to liver microsomal cytochrome P-450E of the marine fish Stenotomus chrysops (scup): cross-reactivity with 3-methylcholanthrene induced rat cytochrome P-450. Arch. Biochem. Biophys., 249, 339-350.
66. Tai,H.L., McReynolds,J.H., Goldstein,J.A., Eugster,H.P., Senstag,C., Alworth,W.L. and Olson,J.R. (1993) Cytochrome P4501A1 mediates the metabolism of 2,3,7,8-tetrachlorodibenzofuran in the rat and human. Toxicol. Appl. Pharmacol., 123, 34-42.
67. 2+-sedimented microsomes from rat liver. Biochem. Pharmacol., 21, 3249-3256.
68. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem., 72, 248-254.
69. Smith,P.F., McKee,R., Gandolfi,A.J., KrumdieckC.L. and Fisher,R. (1989) Precision-cut liver slices: a new in vitro tool in toxicology. In McQueen,C.A. (ed.) In Vitro Toxicology: Model Systems and Methods. Telford Press, Caldwell, NJ, p. 93.
70. Laemmli,V.K. (1970) Change in the structural protein during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
71. Guengerich,F.P., Wang,P. and Davidson,N.K. (1982) Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry, 21, 1698-1706.
72. Bonfils,C. and Combalbert,J. (1990) Resolution of rabbit liver cytochrome P4503b and 3c (P450IIC3 and IIIA4) from microsomal membrane by two-dimensional gel electrophoresis. Electrophoresis, 11, 182-186.
73. O'Farrell,P.Z., Goodman,H.M. and O'Farrell,P.H. (1977) High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell, 12, 1133-1142.
74. Prough,R.A., Burke,M.D. and Mayer,R.T. (1978) Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol., 52, 372-377.
75. Sivaraman,L., Leatham,M.P., Yee,J., Wilkens,L.R., Lau,A.F. and Le Marchand,L. (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res., 54, 3692-3695.
76. Morrison,H.G., Oleksiak,F., Cornell,N.W., Sogin,M.L. and Stegeman,J.J. (1995) Identification of cytochrome P-4501A (CYP1A) genes from two teleost fish, toadfish (Opsanus tau) and scup (Stenotomus chrysops), and phylogenetic analysis of CYP1A genes. Biochem. J., 308, 97-104.
77. Kloepper-Sams,P.J., Park,S.S., Gelboin,H.V. and Stegeman,J.J. (1987) Specificity and cross-reactivity of monoclonal and polyclonal antibodies against cytochrome P-450E of the marine fish scup. Arch. Biochem. Biophys., 253, 268-278.
78. Guo,Z., Gillam,E.M.J., Ohmori,S., Tukey,R.H. and Guengerich,F.P. (1994) Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys., 312, 436-446.
79. Beltzer,J.P. and Spiess,M. (1991) In vitro binding of the asialoglycoprotein receptor to the β adaptin of plasma membrane coated vesicles. EMBO J., 10, 3735-3742.
80. Imamura,M. and Masaki,T. (1994) Identification of a 115-kDa protein from muscle tissues: expression of a nocel nonmuscle α-actinin in vascular endothelial cells. Exp. Cell Res., 211, 380-390.
81. Pastrakuljic,A., Tang,B.K., Roberts,E.A. and Kalow,W. (1997) Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochem. Pharmacol., 53, 531-538.
82. Sandhu,P., Guo,Z., Baba,T., Martin,M.V., Tukey,R.H. and Guengerich,F.P. (1993) Expression of modified human cytochrome P4501A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys., 309, 168-177.